SINCALIDE

NDC 63323-579 · Fresenius Kabi USA, LLC

Generic namesincalide

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)SINCALIDE

Strength5 ug/5mL

Pharmacologic classCholecystokinin Analog [EPC], Cholecystokinin [CS]

Marketing categoryNDA

Packages

63323-579-05 — 10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01)

J2805 — Injection, sincalide, 5 micrograms Medicare Part B payment limit (ASP + 6%): $110.46

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.